Rating Change
Citizens reiterated its Market Outperform rating on Spruce Biosciences, Inc. (NASDAQ:SPRB) on August 13, 2026.
reiterateNASDAQ:SPRB
Citizens Reiterates Market Outperform Rating on Spruce Biosciences, Inc. (SPRB)
Citizens reiterated its Market Outperform rating on Spruce Biosciences, Inc. (NASDAQ:SPRB) on August 13, 2026.
At publication ·
What changed
Spruce Biosciences, Inc. (NASDAQ:SPRB) · reiterate
- Firm
- Citizens
- Rating
- Market Outperform to Market Outperform
- Price at event
- $49.77
- Market capitalization
- $51.6M
At a glance
Key takeaways
- Spruce Biosciences (SPRB) trades at $49.77 with a market capitalization of $51.6 million and has gained 508.7% over the past 52 weeks.
Market Context
Spruce Biosciences, Inc. operates in the Healthcare sector. The stock currently trades at $49.77 with a market capitalization of $51.6M. The stock has gained 508.7% over the past 52 weeks.
Analyst coverage from Citizens provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Spruce Biosciences, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Spruce Biosciences, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 13, 2026 | Citizens | Market Outperform | N/A |
| Jul 13, 2026 | B. Riley Securities | Buy | N/A |
| Jun 16, 2026 | Guggenheim | Buy | N/A |
| Jun 09, 2026 | Jones Trading | Buy | N/A |
| Jun 01, 2026 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View SPRB Stock Page
Frequently Asked Questions
What does the Market Outperform rating mean for SPRB?
A rating of Market Outperform from Citizens reflects the analyst's outlook on Spruce Biosciences, Inc. (NASDAQ:SPRB). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the SPRB forecast page.